Menu
Home
Products
Specialties
Events
Services
Contact Janssen
Menu
Products
Specialties
Events
Services
Contact Janssen
Tremfya-Pso/PsA mode of Action
Media Center
Tremfya
®
is the first biologic indicated for the management of PsA, fully human monoclonal antibody (mAb) that selectively targets IL‑231-3